Effectiveness and safety of updosing of Bilastine in uncontrolled chronic spontaneous urticaria
Not Applicable
- Conditions
- Health Condition 1: L509- Urticaria, unspecified
- Registration Number
- CTRI/2021/08/035626
- Lead Sponsor
- Dr Sankha Subhra Chakraborty
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
INCLUSION CRITERIA:
Male or female patients 18-65 years (both inclusive)
Patients having uncontrolled chronic spontaneous urticaria UAS score>=7(urticaria activity score ),after being treated with H1 antihistamine in standard dose(other than BILASTINE).
Exclusion Criteria
Acute urticria, Physical urticaria, chronic Inducible urticaria,contact urticaria
Systemic diseases and infections
Herediary angioedema,atopic dermatitis
Preganancy and lactation
Known hypersensivity to Bilastine
Corticosteroid use (systemic/topical) in recent times for same condition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method